Search PubMed⌕ Search

Biomedical subjects

M Cormier

Publications and source records attributed to M Cormier.

At least 73 records · Page 4Linked to original sources
PubMed1978

[Acute, lethal miliary tuberculosis due to Mycobacterium bovis].

The authors report a case of lethal acute miliary with bovine tuberculous bacilli. They stress the main characteristics of this exceptional observation :--difficulties in isolating and identifying,--favourable disposition linked to age and to a depressed cellular immunity,--pathogenic interest in the mechanisms of late endogenous reinfestation and of suffocating acute evolution.

Acute Disease↗
PubMed1977

[Behavior of alpha-tocopherol during the autoxidation of linoleic acid in aqueous solution].

Addition of great quantity of alpha-tocopherol to an aqueous solution containing linoleic acid dispersed with twen 20 conduce to an important augmentation of the rate of formation of linoleic hydroperoxides. In these particular conditions, alpha-tocopherol have a prooxidant effect. In the same time, alpha-tocopherol is rapidly transformed into tocopherylquinone and a dimer of alpha-tocopherol. Transitorily there is formation of a dihydroxydimer of alpha-tocopherol. Comparison of these compounds behaviour on the oxydation rate of linoleic acid in the same conditions show a near relation between a prooxidant effect and chemical structure of these compounds as well as alpha-tocopherol. So, alpha-tocopherol and its dihydroxydimer are both prooxidant and both have a free hydroxyl on carbon 6. Dimer of alpha-tocopherol and tocopherylquinone are both antioxidant and they have neither free hydroxyl on carbon 6. alpha-tocopherol acetate in the same conditions have an antioxidant comportment. This confirms the importance of free hydroxyl on carbon 6 to obtain a prooxidant effect.

Antioxidants↗
PubMed1976

[Application of the distal bronchial brushing technic to the bacteriological diagnosis of pulmonary tuberculosis].

The tubercle bacillus was sought in samples obtained by bronchial brushing in 36 patients whose tuberculosis was demonstrated and in whom a direct examination of the sputum had given only negative results. In 5 cases, the tubercle bacillus was demonstrated only in the sample obtained by brushing, by direct examination and positive cultures in one case and in the other cases, culturutum coughed up after brushing.

Bacteriological Techniques↗
PubMedDate not supplied

Osseous concentrations of gentamicin after implantation of acrylic bone cement in sheep femora.

17 sheep received femoral implantation of 'Cérafix Genta', containing gentamicin 0.6 or 1.2 g per dose either unilaterally (first 3 sheep) or bilaterally (remaining 14 sheep). Highest concentrations in bone were measured after 24 and 48 post-operative hours (respectively 36 and 72 mg/kg for Cérafix 0.6 g and 1.2 g). Gentamicin concentrations in bone marrow and femoral heads were in the same range. Blood and urine concentrations of gentamicin measured in sheep were comparable to those obtained in man. An extrapolation of the gentamicin behaviour from sheep to humans, might be possible: the sheep weight and femoral dimensions were comparable to those of humans and the method of implantation was similar in man and animal. For up to 18 months after operation, gentamicin levels in bone were always higher than critical concentration (4 mg/kg). For the early post-operative period, blood and urine levels always remained below gentamicin toxic concentrations.

Acrylates↗
PubMedDate not supplied

Erythromycin lactobionate: pharmacokinetics and uterine tissue levels.

Erythromycin is well-known for its properties of tissular diffusion. An estimation of its concentration in uterine tissue seemed worthwhile, in order to justify the use of erythromycin lactobionate in uterine infections by sensitive micro-organisms. The authors studied the uterine levels of this macrolid, after perfusion of 1g of erythromycin lactobionate, over a period of one hour. The protocol involved a group of 15 women, who were to undergo a hysterectomy for benign non-inflammatory pathology. The uterine specimens and plasmatic pharmacokinetics of the antibiotic constitute the data. The concentrations of antibiotic were determined by microbiological methods. 2 sets of results emerge: during perfusion, the uterine erythromycin levels are equal or inferior to simultaneous serum levels. after perfusion, the uterine levels are superior to serum levels. A bicompartmental linear model was used, which simulated the tissular levels in standard treatment with erythromycin lactobionate. If the erythromycin 4 micrograms/ml critical concentration is compared with uterine tissue concentration, the antibiotic may be expected to be active against a uterine affected by sensitive micro-organisms during a period of approximately 5 hours. This result must be confirmed by a clinical study.

Adult↗